Article Detail - JF Part B
MolDX: Pharmacogenomics Testing Local Coverage Determination
This Local Coverage Determination (LCD) has completed the Open Public Meeting comment period and is now finalized under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY). Responses to comments received may be found as a link at the bottom of the final LCD.
|Medicare Coverage Database Number||LCD Title|
|L38337||MolDX: Pharmacogenomics Testing|
Effective Date: 08/17/2020
Summary: These tests are generally covered (with a few exceptions) to improve safety in the use of specific medications by avoiding potentially harmful medications, doses and/or adverse reactions known to occur with certain genotypes. There is no billing and coding article associated with this LCD.
Visit the Future LCDs webpage to access this LCD.
Last Updated Wed, 01 Jul 2020 17:19:09 +0000